Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets.

IF 4.1 2区 医学 Q2 MICROBIOLOGY
Tamara V Milosevic, Gaëlle Vertenoeil, William Vainchenker, Paul M Tulkens, Stefan N Constantinescu, Françoise Van Bambeke
{"title":"Oxazolidinone antibiotics impair <i>ex vivo</i> megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets.","authors":"Tamara V Milosevic, Gaëlle Vertenoeil, William Vainchenker, Paul M Tulkens, Stefan N Constantinescu, Françoise Van Bambeke","doi":"10.1128/aac.00533-24","DOIUrl":null,"url":null,"abstract":"<p><p>Oxazolidinones (linezolid and tedizolid) adverse reactions include thrombocytopenia, the mechanism of which is still largely unknown. In cultured cells, oxazolidinones impair mitochondrial protein synthesis and oxidative metabolism. As mitochondrial activity is essential for megakaryocyte differentiation and maturation into platelets, we examined whether oxazolidinones impair these processes <i>ex vivo</i> and alter, in parallel, the activity of mitochondrial cytochrome <i>c</i>-oxidase (CYTOX; enzyme partly encoded by the mitochondrial genome) and cell morphology. Human CD34+ cells were isolated, incubated with cytokines (up to 14 days) and clinically relevant oxazolidinone concentrations or in control conditions, and used for (i) clonogenic assays [counting of megakaryocyte (CFU-Mk), granulocyte-monocyte (CFU-GM), burst-forming unit-erythroid (BFU-E) colonies]; (ii) the measure of the expression of megakaryocyte surface antigens (CD34 to CD41 and CD42); (iii) counting of proplatelets; (iv) the measurement of CYTOX activity; and (v) cell morphology (optic and electron microscopy). Oxazolidinones caused a significant decrease in BFU-E but not CFU-Mk or CFU-GM colonies. Yet, the megakaryocytic lineage was markedly affected, with a decreased differentiation of CD34+ into CD41+/CD42+ cells, an abolition of proplatelet formation and striking decrease in the numbers of large polylobulated nucleus megakaryocytes, with a complete loss of intracellular demarcation membrane system, disappearance of mitochondria, and suppression of CYTOX activity. These alterations were more marked in cells incubated with tedizolid than linezolid. These data suggest that oxazolidinones may induce thrombocytopenia by impairing megakaryocytic differentiation through mitochondrial dysfunction. Pharmacological interventions to prevent this toxicity might therefore be difficult as mitochondrial toxicity is most probably inherently linked to their antibacterial activity.</p>","PeriodicalId":8152,"journal":{"name":"Antimicrobial Agents and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":4.1000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial Agents and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/aac.00533-24","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Oxazolidinones (linezolid and tedizolid) adverse reactions include thrombocytopenia, the mechanism of which is still largely unknown. In cultured cells, oxazolidinones impair mitochondrial protein synthesis and oxidative metabolism. As mitochondrial activity is essential for megakaryocyte differentiation and maturation into platelets, we examined whether oxazolidinones impair these processes ex vivo and alter, in parallel, the activity of mitochondrial cytochrome c-oxidase (CYTOX; enzyme partly encoded by the mitochondrial genome) and cell morphology. Human CD34+ cells were isolated, incubated with cytokines (up to 14 days) and clinically relevant oxazolidinone concentrations or in control conditions, and used for (i) clonogenic assays [counting of megakaryocyte (CFU-Mk), granulocyte-monocyte (CFU-GM), burst-forming unit-erythroid (BFU-E) colonies]; (ii) the measure of the expression of megakaryocyte surface antigens (CD34 to CD41 and CD42); (iii) counting of proplatelets; (iv) the measurement of CYTOX activity; and (v) cell morphology (optic and electron microscopy). Oxazolidinones caused a significant decrease in BFU-E but not CFU-Mk or CFU-GM colonies. Yet, the megakaryocytic lineage was markedly affected, with a decreased differentiation of CD34+ into CD41+/CD42+ cells, an abolition of proplatelet formation and striking decrease in the numbers of large polylobulated nucleus megakaryocytes, with a complete loss of intracellular demarcation membrane system, disappearance of mitochondria, and suppression of CYTOX activity. These alterations were more marked in cells incubated with tedizolid than linezolid. These data suggest that oxazolidinones may induce thrombocytopenia by impairing megakaryocytic differentiation through mitochondrial dysfunction. Pharmacological interventions to prevent this toxicity might therefore be difficult as mitochondrial toxicity is most probably inherently linked to their antibacterial activity.

噁唑烷酮类抗生素会损害体内巨核细胞从造血祖细胞分化并成熟为血小板。
恶唑烷酮类药物(利奈唑烷和泰迪唑烷)的不良反应包括血小板减少,其机制尚不清楚。在培养细胞中,恶唑烷酮会损害线粒体蛋白质合成和氧化代谢。由于线粒体活性对巨核细胞分化和成熟为血小板至关重要,我们研究了恶唑烷酮类药物是否会损害这些体内过程,并同时改变线粒体细胞色素 c-氧化酶(CYTOX;部分由线粒体基因组编码的酶)的活性和细胞形态。分离人 CD34+ 细胞,与细胞因子(长达 14 天)和临床相关浓度的噁唑烷酮或在对照条件下孵育,并用于 (i) 克隆生成试验[巨核细胞(CFU-Mk)、粒细胞-单核细胞(CFU-GM)、爆发形成单位-红细胞(BFU-E)菌落计数];(ii) 巨核细胞表面抗原(CD34、CD41 和 CD42)的表达测量;(iii) 原血小板计数;(iv) CYTOX 活性测量;以及 (v) 细胞形态学(光学和电子显微镜)。噁唑烷酮类药物可显著减少 BFU-E,但不会减少 CFU-Mk 或 CFU-GM 菌落数。然而,巨核细胞系受到明显影响,CD34+细胞向CD41+/CD42+细胞分化减少,原血小板形成消失,多核巨核细胞数量显著减少,细胞内分界膜系统完全丧失,线粒体消失,CYTOX活性受到抑制。与利奈唑胺相比,用泰迪唑胺培养的细胞发生的这些变化更为明显。这些数据表明,噁唑烷酮类药物可能会通过线粒体功能障碍损害巨核细胞分化,从而诱发血小板减少症。由于线粒体毒性很可能与其抗菌活性有内在联系,因此很难通过药物干预来预防这种毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.00
自引率
8.20%
发文量
762
审稿时长
3 months
期刊介绍: Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信